期刊文献+

黛力新联合心理干预治疗偏头痛的临床研究 被引量:5

Clinical Study of Deanxit Combined with Psychological Intervention in Treatment of Migraine
下载PDF
导出
摘要 目的探讨黛力新联合心理干预治疗对偏头痛患者的疗效。方法随机将60例偏头痛患者分为两组,对照组常规治疗,治疗组联用黛力新和心理治疗,疗程8周。两组在入组前及治疗后8周分别记录临床症状,观察药物的不良反应,并同步进行90项症状自评量表(SCL-90)总分评定和5-羟色胺含量的测定,随访1年。结果治疗组有效率90.0%,对照组有效率73.3%,两组比较差异具有统计学意义(χ2=4.565,P<0.05);1年后随访,治疗组30例无一例复发,而对照组6例复发,差异具有统计学意义(χ2=5.163,P<0.05)。治疗8周后两组SCL-90总分和血5-羟色胺的下降幅度治疗组明显高于对照组。结论联用抗焦虑药物和心理综合方法治疗偏头痛患者,临床症状改善明显,不良反应小,复发率低。 Objective To investigate the curative effect of deanxit combined with psychological intervention for the treatment of migraine patients.Methods 60 migraine patients were divided into two groups,control group with conventional treatment for migraine while the case group combined with deanxit and psychological treatment,all treatment continued for 8 weeks,of the two groups,before and after treatment 8 weeks.Both groups were recorded clinic symptoms and were assessed by symptom checklist-90(SCL-90)score,plasma 5-HT was also detected at the same time.All of patients were followed-up for 1 year.Results In treatment group,the effective rate was 90.0% while 73.3% in the control group,the difference was statistically significant(χ2=4.565,P〈0.05);with 1-year follow-up,in the treatment group,all 30 cases had no recurrence,while the control group 6 cases of recurrence,the difference was statistically significant(χ2=5.163,P〈0.05).After 8 weeks of the treatment,the decline of SCL-90 total score and blood 5-HT in treatment group were significantly higher than that in control group.Conclusion Clinical symptoms improved significantly when comprehensive anti-anxiety drugs combined with psychological treatment for patients with migraine,are administered the recurrence rate and side effects are lower.
出处 《医学综述》 2012年第4期630-631,共2页 Medical Recapitulate
关键词 偏头痛 黛力新 心理干预 Migraine Deanxit Psychological intervention
  • 相关文献

参考文献11

二级参考文献73

  • 1郭述苏,薛慎伍,陈同慧,樊红,任旭东,曲伸.典型偏头痛诱发因素及阻断试验[J].临床神经病学杂志,1994,7(3):133-135. 被引量:11
  • 2邵福源,黄流清,吴萍嘉,谈永基,余慧贞,章瑛,蔡琰,戴志仙,苗玲.口服舒马曲坦治疗偏头痛83例[J].新药与临床,1994,13(4):194-196. 被引量:22
  • 3汪向东 王希林 等.心理卫生评定量表手册[M].北京:中国心理卫生杂志社,1999.235.
  • 4王荣国 李光华.内科疾病诊断标准[M].上海:上海科学技术出版社,1993.325-326.
  • 5冯应棍.临床脑电图学[M].北京:人民卫生出版社,1984:61.
  • 6胡兆昆.神经科·神经外科学手册.国外医学,1984,:38-38.
  • 7[1]Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA, 2001, 98:4687-4692.
  • 8[2]Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci, 2003, 4:386-398.
  • 9[3]Kruuse C, Thomsen LL, Birk S, et al. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain,2003, 126:241-247.
  • 10[4]Lauritzen M. Pathophysiology of the migraine aura: the spreading depression theory. Brain, 1994, 117:199-210.

共引文献46

同被引文献26

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部